EAM Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

EAM Investors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90,079	Closed	-$2.19M	–	403
2023 Q1	$2.19M	Sell	90,079 -10,192	-10%	-$223K	0.43%	84
2022 Q4	$2.15M	Sell	100,271 -51,422	-34%	-$1.1M	0.44%	75
2022 Q3	$2.72M	Buy	+151,693	New	+$1.99M	0.59%	45
2022 Q2	–	Sell	-155,778	Closed	-$2.62M	–	384
2022 Q1	$2.62M	Sell	155,778 -34,235	-18%	-$506K	0.49%	65
2021 Q4	$3.18M	Sell	190,013 -45,074	-19%	-$739K	0.52%	47
2021 Q3	$3.82M	Buy	+235,087	New	+$2.56M	0.64%	28
2016 Q2	–	Sell	-48,341	Closed	-$2.04M	–	388
2016 Q1	$2.04M	Buy	48,341 +6,342	+15%	+$323K	0.32%	152
2015 Q4	$3.3M	Buy	+41,999	New	+$2.43M	0.43%	88
2015 Q2	–	Sell	-58,212	Closed	-$2.71M	–	384
2015 Q1	$2.71M	Buy	58,212 +97	+0.2%	+$5.04K	0.31%	163
2014 Q4	$2.61M	Buy	58,115 +19,125	+49%	+$803K	0.36%	98
2014 Q3	$1.52M	Buy	38,990 +7,058	+22%	+$277K	0.31%	133
2014 Q2	$1.35M	Buy	+31,932	New	+$1.17M	0.26%	194

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

EAM Investors's ISEE Position: Q2 2023 in Review

EAM Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 90,079 shares — an estimated $2.19M sold.

EAM Investors first reported a position in ISEE in Q2 2014 and held it in 12 quarters. The position peaked at $3.82M in Q3 2021. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

EAM Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
EAM Investors sold 90,079 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $2.19M.
EAM Investors first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 12 quarters.
EAM Investors's IVERIC bio, Inc. Common Stock position peaked at $3.82M in Q3 2021.
255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.